Table 2 Characteristics of degenerative and control group data
Degenerative group (n = 101) | Control group (n = 134) | P value | ANCOVA analysis of age-adjusted P value | |
|---|---|---|---|---|
Age(years) | 61.8 ± 8.1 | 59.4 ± 7.8 | 0.026 | – |
Female | 49 (48.5%) | 97 (72.3%) | < 0.0001 | – |
BMI(kg/m2) | 24.0 ± 3.2 | 23.9 ± 3.1 | 0.729 | 0.746 |
Smoking habits | 4 (2.9%) | 6 (5.9%) | 0.433 | – |
Alcohol consumption | 3 (2.2%) | 2 (1.9%) | 0.57 | – |
Comorbidities | ||||
Diabetes | 17 (12.6%) | 13 (12.8%) | 0.966 | – |
Hypertension | 33 (24.6%) | 28 (27.7%) | 0.592 | – |
Rheumatic diseases | 3 (2.2%) | 4 (3.9%) | 0.703 | – |
Osteoporosis treatment | ||||
Antiresorptive medications | 9 (8.9%) | 11 (8.2%) | 0.894 | – |
Anabolic medications | 3 (3%) | 5 (3.7%) | 0.75 | – |
Osteopenia/osteoporosis | ||||
Prior diagnosed | 18 (17.8%) | 22 (16.4%) | 0.777 | – |
Current diagnosed | 85 (63.4%) | 66 (65.3%) | 0.762 | – |
VBQ | 2.9 ± 0.5 | 2.8 ± 0.5 | 0.012 | 0.047 |
HU Value | 109.7 ± 37.6 | 130.2 ± 37.6 | < 0.0001 | 0.001 |
L1-4 BMD(g/cm2) | 1.015 ± 0.172 | 0.965 ± 0.151 | 0.018 | 0.006 |
L1-4 T-score | − 0.69 ± 1.50 | − 1.15 ± 1.27 | 0.011 | 0.003 |
Femoral neck BMD(g/cm2) | 0.848 ± 0.139 | 0.86 ± 0.119 | 0.478 | 0.98 |
Femoral neck T-score | − 0.85 ± 0.14 | − 0.64 ± 1.01 | 0.157 | 0.484 |
Total hip BMD(g/cm2) | 0.908 ± 0.146 | 0.907 ± 0.120 | 0.984 | 0.625 |
Total hip T-score | − 0.57 ± 1.09 | − 0.53 ± 0.92 | 0.755 | 0.865 |
Lowest BMD(g/cm2) | 0.821 ± 0.136 | 0.833 ± 0.115 | 0.444 | 0.888 |
Lowest T-score | − 1.41 ± 1.12 | − 1.48 ± 1.04 | 0.605 | 0.284 |